News
12-12-2019, 08:32 AM
The Queen Mary University of London professor leading an international breast cancer study says anastrozole - rather than tamoxifen - should be the preventive drug-of-choice for post-menopausal women at increased risk of developing the disease.
More... (https://www.news-medical.net/news/20191212/Anastrozole-can-be-preventive-drug-of-choice-for-womenc2a0with-high-breast-cancer-risk.aspx)
More... (https://www.news-medical.net/news/20191212/Anastrozole-can-be-preventive-drug-of-choice-for-womenc2a0with-high-breast-cancer-risk.aspx)